中财网 中财网股票行情
恩华药业(002262)财务分析指标    年份：
截止日期2024-09-302024-06-302024-03-312023-12-312023-09-30
营业总收入(万元)414546.31276339.81135756.57504150.45365598.52
营业收入(万元)414546.31276339.81135756.57504150.45365598.52
营业总成本(万元)302427.18203408.29106692.73396039.62269274.46
营业成本(万元)108807.2675996.7139670.69136984.3198315.86
净利润(万元)102010.7162892.0326528.22103056.9288564.13
归属于母公司的净利润(万元)102010.7162892.0326528.22103691.8188564.13
营业利润(万元)117139.3473255.3830487.13118234.42100545.69
利润总额(万元)115239.8372099.2529973.61116864.41100077.48
少数股东损益(万元)-356.99-234.67-64.35-267.08-222.66
基本每股收益(元)1.01(元)0.62(元)0.26(元)1.03(元)0.88(元)
稀释每股收益(元)1.01(元)0.62(元)0.26(元)1.03(元)0.88(元)
非经常性损益(万元)-1035.67---200.412384.30-2.21
扣除非经常性损益后净利润(万元)103046.3863397.5226728.64101307.5188566.34
总资产(万元)812890.88764239.03760395.48732819.54713916.52
总负债(万元)102469.2192813.7392920.8491808.7787251.20
归属于母公司股东权益合计(万元)713182.04674063.36669942.37643414.15630637.23
股东权益合计(万元)710421.67671425.30667474.64641010.77626665.32
实收资本(股本)(万元)101617.68100758.81100758.81100758.81100758.81
资本公积(万元)19325.3010298.5810298.5810298.5811941.04
未分配利润(万元)551069.81511951.12507830.14481301.91466247.65
经营活动产生的现金流量净额(万元)91119.2762183.7123358.23100830.0081864.88
经营活动现金流入小计(万元)454867.41294823.78146640.08539148.90405573.01
经营活动现金流出小计(万元)363748.14232640.08123281.85438318.90323708.13
投资活动产生的现金流量净额(万元)-120664.57-94908.20-67352.19-29339.09-6782.85
投资活动现金流入小计(万元)472498.04248556.54101172.57653422.82480095.03
投资活动现金流出小计(万元)593162.61343464.73168524.75682761.91486877.89
筹资活动产生的现金流量净额(万元)-26569.79-30978.90195.10-21017.37-22655.57
筹资活动现金流入小计(万元)16353.344975.822000.008000.004000.00
筹资活动现金流出小计(万元)42923.1335954.711804.9029017.3726655.57
期末现金及现金等价物余额(万元)144867.51137275.62157175.40200961.28202665.40
最后修改日期2024-10-292024-07-302024-04-202024-04-012023-10-26
↑返回页顶↑

转至恩华药业（002262）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。